Karyopharm Therapeutics Inc. short interest in 2023
In 2023, Karyopharm Therapeutics Inc.'s disclosed short interest ran from 26.70% of shares outstanding on 13 Jan 2023 to 15.67% on 29 Dec 2023, a change of -11.03 percentage points. The year's high was 28.51% on 31 Jan 2023 and its low 11.01% on 30 Jun 2023, averaging 15.90% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.14 days on 30 Nov 2023. Full history: Karyopharm Therapeutics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 26.70% (13 Jan 2023)
- End of year
- 15.67% (29 Dec 2023)
- Change
- -11.03 pp
- High
- 28.51% (31 Jan 2023)
- Low
- 11.01% (30 Jun 2023)
- Average
- 15.90%
- Highest days to cover
- 22.14 (30 Nov 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 26.70% | 4.88 | results (8-K) |
| 31 Jan 2023 | 28.51% | 9.77 | |
| 15 Feb 2023 | 18.82% | 9.91 | results (8-K) |
| 28 Feb 2023 | 16.17% | 8.93 | 10-K filed |
| 15 Mar 2023 | 14.76% | 7.53 | |
| 31 Mar 2023 | 16.85% | 6.58 | |
| 14 Apr 2023 | 15.67% | 8.28 | |
| 28 Apr 2023 | 15.75% | 7.45 | |
| 15 May 2023 | 15.02% | 4.66 | 10-Q filed, results (8-K) |
| 31 May 2023 | 14.45% | 8.17 | |
| 15 Jun 2023 | 14.49% | 7.23 | |
| 30 Jun 2023 | 11.01% | 2.63 | |
| 14 Jul 2023 | 12.15% | 6.86 | |
| 31 Jul 2023 | 13.12% | 2.67 | |
| 15 Aug 2023 | 12.69% | 10.25 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 12.86% | 9.50 | |
| 15 Sep 2023 | 13.15% | 12.70 | |
| 29 Sep 2023 | 14.55% | 9.16 | |
| 13 Oct 2023 | 15.38% | 20.35 | |
| 31 Oct 2023 | 15.64% | 17.77 | |
| 15 Nov 2023 | 16.49% | 18.15 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 16.18% | 22.14 | |
| 15 Dec 2023 | 15.49% | 12.59 | |
| 29 Dec 2023 | 15.67% | 11.48 |
See also: Karyopharm Therapeutics Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.